Special items: Ovarian Cancer and Us blog best viewed in Firefox

Monday, April 05, 2010

abstract: pre-clinical - A Novel Breast/Ovarian Cancer Peptide Vaccine Platform That Promotes Specific Type-1 but not Treg/Tr1-type Responses - DepoVax

DepoVax

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.